Open access · CC-BY
via OpenAlex
Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
Carl Randall Harrell, Crissy Fellabaum, Nemanja U. Jovicic, Valentin Djonov, Nebojša Arsenijević, Vladislav Volarević
Cells · 2019 · ▲ 520 citations
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Stem-cell therapy
Partial reprogramming (OSK)
Cell culture / in vitro
Review
Abstract
Mesenchymal stem cell (MSC)-sourced secretome, defined as the set of MSC-derived bioactive factors (soluble proteins, nucleic acids, lipids and extracellular vesicles), showed therapeutic effects similar to those observed after transplantation of MSCs. MSC-derived secretome may bypass many side effects of MSC-based therapy, including unwanted differentiation of engrafted MSCs. In contrast to MSCs which had to be expanded in culture to reach optimal cell number for transplantation, MSC-sourced secretome is immediately available for treatment of acute conditions, including fulminant hepatitis, cerebral ischemia and myocardial infarction. Additionally, MSC-derived secretome could be massively produced from commercially available cell lines avoiding invasive cell collection procedure. In this review article we emphasized molecular and cellular mechanisms that were responsible for beneficial effects of MSC-derived secretomes in the treatment of degenerative and inflammatory diseases of hepatobiliary, respiratory, musculoskeletal, gastrointestinal, cardiovascular and nervous system. Results obtained in a large number of studies suggested that administration of MSC-derived secretomes represents a new, cell-free therapeutic approach for attenuation of inflammatory and degenerative diseases. Therapeutic effects of MSC-sourced secretomes relied on their capacity to deliver genetic material, growth and immunomodulatory factors to the target cells enabling activation of anti-apoptotic and pro-survival pathways that resulted in tissue repair and regeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cells8050467
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Harrell, C.R., Fellabaum, C., Jovicic, N.U., Djonov, V., Arsenijević, N., & Volarević, V. (2019). Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. <em>Cells</em>. https://doi.org/10.3390/cells8050467
Vancouver
Harrell CR, Fellabaum C, Jovicic NU, Djonov V, Arsenijević N, Volarević V. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019. doi:10.3390/cells8050467.
BibTeX
@article{carl2019Molecu,
title = {Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome},
author = {Carl Randall Harrell and Crissy Fellabaum and Nemanja U. Jovicic and Valentin Djonov and Nebojša Arsenijević and Vladislav Volarević},
journal = {Cells},
year = {2019},
doi = {10.3390/cells8050467},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2019
Open access · CC-BY
Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
Stem Cell Research & Therapy 2025
Open access · CC-BY
Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases
Stem Cells International 2019
Open access · CC-BY
Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
World Journal of Gastroenterology 2015
Open access · CC-BY
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
Bulletin Biomedicine and sociology 2024
Citation only
MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM
Astana Medical Journal 2026
Open access · OA